Connect your AI

Vericel VCEL Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

LeMaitre VascularLMAT

$19.83M+22.2%

Capricor TherapeuticsCAPR

$13.16M+1,067%

Globus MedicalGMED

6.9%+1.6pp

EnovisENOV

——

Other financials

Income statement

Revenue$68.4M+30.1%

Gross profit$49.3M+35.8%

Operating income-$8.1M+37.0%

Net income-$6.3M+44.0%

EPS (diluted)-$0.12+47.8%

Balance sheet

Cash & equivalents$109.3M+37.1%

Total debt$95.0M-4.6%

Total equity$356.2M+20.6%

Total assets$485.6M+14.4%

Cash flow

Operating cash flow$16.4M+148%

CapEx$1.3M-91.2%

Free cash flow$15.1M+299%

Valuation

Market cap$2.13B-26.8%

Profitability

Gross margin74.8%+2.3pp

Operating margin5.4%+4.6pp

Net margin7.3%+6.1pp

FCF margin16.3%—

Returns & leverage

Return on equity6.6%+5.5pp

Debt / equity0.3×-0.1×

Current ratio5.2×+0.2×

Where this comes from

Reported directly by Vericel in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Vericel’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vericel's operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Vericel's operating lease ROU assets?: Vericel (VCEL) reported operating lease ROU assets of $63.41M in Q1 2026.
How has Vericel's operating lease ROU assets changed year-over-year?: Vericel's operating lease ROU assets decreased by 7.7% year-over-year, from $68.72M to $63.41M.
What is the long-term trend for Vericel's operating lease ROU assets?: Over 5 years (2020 to 2025), Vericel's operating lease ROU assets has grown at a 5.3% compound annual growth rate (CAGR), from $50.11M to $64.77M.
What does operating lease ROU assets mean?: Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.